A consensus statement on the gender perspective in lung cancer

D. Isla, M. Majem, N. Viñolas, A. Artal, A. Blasco, E. Felip, P. Garrido, J. Remón, M. Baquedano, J. M. Borrás, M. Die Trill, R. García-Campelo, O. Juan, C. León, P. Lianes, F. López-Ríos, L. Molins, M. Planchuelo, M. Cobo, L. Paz-AresJ. M. Trigo, J. de Castro

Research output: Contribution to journalReview articlepeer-review

29 Citations (Scopus)

Abstract

Lung cancer is the most common cancer globally and has the highest mortality. Although this disease is not associated with a particular gender, its incidence is rising among women, who are diagnosed at an increasingly younger age compared with men. One of the main reasons for this rise is women taking up smoking. However, many non-smoking women also develop this disease. Other risk factors implicated in the differential development of lung cancer in women are genetic predisposition, tumour histology and molecular profile. Proportionally more women than men with lung cancer have a mutation in the EGFR gene. This consensus statement reviews the available evidence about the epidemiological, biological, diagnostic, therapeutic, social and psychological aspects of lung cancer in women.

Original languageEnglish
Pages (from-to)527-535
Number of pages9
JournalClinical and Translational Oncology
Volume19
Issue number5
DOIs
Publication statusPublished - 1 May 2017
Externally publishedYes

Keywords

  • EGFR
  • Gender
  • Lung cancer
  • Quality of life
  • Smoking

Cite this